Abstract
Intravenous thrombolysis (IVT) is a standard treatment for acute ischemic stroke (AIS), yet it remains underutilized in dialysis-dependent (DD) patients due to concerns regarding systemic health and coagulation. This study investigates the short-term in-hospital complications for DD patients receiving IVT. Utilizing the Nationwide Inpatient Sample (NIS) from 2012–2015, we found that while DD patients experience lower rates of intracerebral hemorrhage (ICH) and urinary tract infections (UTI), they face significantly higher risks of sepsis, pneumonia, and deep venous thrombosis (DVT). These findings suggest that clinical focus should shift toward aggressive infection and clot prevention to improve outcomes in this high-risk population.
Introduction
When treating acute ischemic stroke, intravenous thrombolysis is the primary pharmacological intervention to restore blood flow. However, the risk of hemorrhage often leads to the exclusion of complex patient populations from clinical trials. Patients with end-stage renal disease requiring dialysis are a particularly vulnerable group; their altered blood chemistry and systemic fragility create uncertainty for clinicians. This study aims to delineate the specific complication profile of dialysis-dependent patients to better inform risk management and clinical decision-making.
Methods
This retrospective cohort study analyzed data from the Nationwide Inpatient Sample (NIS) between 2012 and the third quarter of 2015. Using ICD-9 codes, the researchers identified adult patients (18+) admitted for AIS who received IV thrombolysis while on dialysis for renal failure.
The study isolated encounters involving specific in-hospital complications, including:
- Intracerebral hemorrhage (ICH)
- Pneumonia
- Urinary tract infection (UTI)
- Sepsis
- Deep venous thrombosis (DVT)
- Pulmonary embolism (PE)
Comparative analyses were performed between dialysis-dependent (DD) patients and non-dialysis (no DD) patients to assess hospital mortality, length of stay, and complication rates.
Results
The analysis included 5,745 encounters of AIS patients treated with thrombolysis while on dialysis. Among the 189 DD patients identified with complications, several significant trends emerged:
- The ICH Paradox: DD patients had a significantly lower rate of ICH (1.1%) compared to non-DD patients (4.6%, p < 0.0001). This suggests that the primary fear of "brain bleeds" may be less prevalent in this group than previously assumed.
- Infection Risks: Sepsis rates were nearly six times higher in the DD group (11.4% vs. 1.9%, p < 0.0001). Pneumonia was also more frequent (5.4% vs. 2.9%, p < 0.0001), though UTI rates were lower (2.5% vs. 4.2%, p < 0.0001).
- Venous Thromboembolism: DD patients faced a substantially higher risk of DVT (15.6% vs. 3.2%, p = 0.004). There was no significant difference in the rate of pulmonary embolism (3.3% in both groups).
Discussion and Conclusion
The results highlight a distinct complication profile for dialysis-dependent stroke patients. While the lower rate of ICH is surprising given the coagulation complexities of renal failure, the heightened risk of systemic infections and venous clots is a critical clinical finding.
Physicians managing DD patients receiving IV thrombolysis should prioritize aggressive prophylaxis for pneumonia, sepsis, and DVT. Future research is needed to determine if specific thrombolytic agents (such as Tenecteplase vs. Alteplase) offer better safety profiles for this population and to investigate the physiological mechanisms behind the lower ICH rates observed in these patients. Improving short-term outcomes for dialysis-dependent patients requires a shift in focus from purely neurological monitoring to comprehensive systemic complication prevention.
Summary updated